Kibong'oto National Tuberculosis Hospital, Sanya Juu, Tanzania Report issue

Academic/Hospital Phase 2 Phase 4

Organization Overview

First Clinical Trial
2004
NCT00851630
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2010

Timeline

NOW
  • Now

Alternative names

Kibongoto National Tuberculosis Hospital, Tanzania

Active Ingredients

Drugs in Phase 4 Trials (3)

abacavir (ziagen) (1 trial)

lamivudine (epivir) (1 trial)

zidovudine (retrovir) (1 trial)

Drugs in Phase 2 Trials (1)

rifampin (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Immune Reconstitution Inflammatory Syndrome (Phase 4)

Tuberculosis (Phase 4)

Tuberculosis, Pulmonary (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 4